<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02874482</url>
  </required_header>
  <id_info>
    <org_study_id>2013_19.1</org_study_id>
    <secondary_id>2013-A01497-38</secondary_id>
    <nct_id>NCT02874482</nct_id>
  </id_info>
  <brief_title>Cognitive and Emotional Factors in Visual Exploration Among Patients With Schizophrenia</brief_title>
  <acronym>SAILLANCE1</acronym>
  <official_title>Study of Cognitive and Emotional Factors Influencing the Visual Exploration Among Patients With Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:&#xD;
&#xD;
      Patients with schizophrenia are abnormally disturbed by information onsets, which may result&#xD;
      in a disadvantage in filtering relevant information. It seems that they accord the same&#xD;
      importance to all objects in a scene without taking into account the relevance of objects&#xD;
      (cognitive salience) or their emotional charge (salience emotional).&#xD;
&#xD;
      The paradigm of change blindness offers the interesting possibility of studying sensitivity&#xD;
      to the sudden irruption of visual information with ecological stimuli in schizophrenia. An&#xD;
      increased attentional capture by the irruption of visual information would suggest better&#xD;
      performance in patients than in healthy controls. Moreover, patients are disturbed to&#xD;
      processing of emotional information, in this way we would like to measure the impact of&#xD;
      emotional salience on the visual exploration.&#xD;
&#xD;
      Main aim:&#xD;
&#xD;
      The main objective is to evaluate, if patients with schizophrenia quickly detect changes&#xD;
      occurring on irrelevant objects in the understanding of the scene.&#xD;
&#xD;
      Secondary objectives:&#xD;
&#xD;
      To evaluate in patients with schizophrenia the impact of emotional salience using the same&#xD;
      paradigm.&#xD;
&#xD;
      To separate an explicit response (motors responses) with an implicit response (eye tracking&#xD;
      measures).&#xD;
&#xD;
      Methodology:&#xD;
&#xD;
      30 patients with schizophrenia and 30 healthy controls were asked to detect changes in 96&#xD;
      scenes with 0 or 1 change (neutral or emotional changes). We will measure the participants'&#xD;
      speed and accuracy in explicitly reporting the changes via motor responses and their capacity&#xD;
      to implicitly detect changes via eye movements.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will include one visit:&#xD;
&#xD;
        -  Written consent will be obtained from all participants&#xD;
&#xD;
        -  Inclusion and exclusion criteria will be checked&#xD;
&#xD;
        -  An ophthalmologic test, a pregnancy test, a alcohol test and a salivary test will be&#xD;
           realized&#xD;
&#xD;
        -  Various symptoms will be assessed with the PANSS (Positive And Negative Syndrome Scale&#xD;
           for schizophrenia) and the UPDRS (Unified Parkinson Disease Rating Scale for patients,&#xD;
           the MOCA (Montreal Cognitive Assessment), The HAD (Hospital Anxiety and Depression&#xD;
           Scale) and the MINI (Mini International Neuropsychiatric Interview) for all&#xD;
           participants.&#xD;
&#xD;
        -  The task will be divided in two parts:&#xD;
&#xD;
      A visuo-spatial task allowing to record saccadic eye movements (approximately 10 min).&#xD;
&#xD;
      The change blindness session lasted approximately 20 min.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2014</start_date>
  <completion_date type="Actual">November 17, 2019</completion_date>
  <primary_completion_date type="Actual">November 17, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>response time</measure>
    <time_frame>42 months</time_frame>
    <description>The explicit response of the participants will be measure behaviourally by response time before the detection of neutral stimuli.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>sensitivity index</measure>
    <time_frame>42 months</time_frame>
    <description>Performances will be measure by a sensitivity index (D prime) which considers the number of correct detections compared with the missed detections and false alarms; thus it evaluates the capacity to discriminate the signal against a background noise.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>implicit response</measure>
    <time_frame>42 months</time_frame>
    <description>The implicit response will be measure by the localization and duration of fixations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>emotional response</measure>
    <time_frame>42 months</time_frame>
    <description>The emotional response will be measure by the localization, duration of fixations and performances for the detection of emotional stimuli</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">42</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Patients with schizophrenia</arm_group_label>
    <description>30 patients with schizophrenia (diagnosis based on the standard DSM criteria)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>30 healthy controls without any psychiatric or neurological diagnosis</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        30 patients with schizophrenia and 30 healthy controls&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Normal or corrected vision&#xD;
&#xD;
          -  Affiliate to a social security system&#xD;
&#xD;
          -  For group of patients with schizophrenia : diagnosis of schizophrenia based on the&#xD;
             standard DSM-IV criteria and patients will be clinically stable at the testing time&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of neurological illness&#xD;
&#xD;
          -  Pregnant and nursing women&#xD;
&#xD;
          -  Drugs use in the last 24 hours&#xD;
&#xD;
          -  Acute ocular disorder&#xD;
&#xD;
          -  Under tutorship, curatorship or deprived of liberty&#xD;
&#xD;
          -  For controls group : be free DSM-IV axis-I diagnoses according the MINI test.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillaume VAIVA</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital, Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 17, 2016</study_first_submitted>
  <study_first_submitted_qc>August 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2016</study_first_posted>
  <last_update_submitted>August 25, 2020</last_update_submitted>
  <last_update_submitted_qc>August 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Schizophrenia</keyword>
  <keyword>Change blindness</keyword>
  <keyword>Eye tracking</keyword>
  <keyword>Implicit response</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

